Exploring the Role of Genetics in Sarcoidosis and Its Impact on the Development of Cardiac Sarcoidosis.
- Published in:
- Cardiogenetics, 2024, v. 14, n. 2, p. 106, doi. 10.3390/cardiogenetics14020009
- By:
- Publication type:
- Article
Works matching IS 20358253 AND DT 2024 AND VI 14 AND IP 2
Results: 5
1
2
Gene Polymorphisms LEP , LEPR , 5HT2A , GHRL , NPY , and FTO -Obesity Biomarkers in Metabolic Risk Assessment: A Retrospective Pilot Study in Overweight and Obese Population in Romania.
- Published in:
- Cardiogenetics, 2024, v. 14, n. 2, p. 93, doi. 10.3390/cardiogenetics14020008
- By:
- Publication type:
- Article
3
A Single Nucleotide Variant in Ankyrin-2 Influencing Ventricular Tachycardia in COVID-19 Associated Myocarditis.
- Published in:
- Cardiogenetics, 2024, v. 14, n. 2, p. 84, doi. 10.3390/cardiogenetics14020007
- By:
- Publication type:
- Article
4
Anderson–Fabry Disease Homozygosity: Rare Case of Late-Onset Variant.
- Published in:
- Cardiogenetics, 2024, v. 14, n. 2, p. 74, doi. 10.3390/cardiogenetics14020006
- By:
- Publication type:
- Article
5
Consideration of the Medical Economics of Cardiac Genetics, Focusing on the Cost-Effectiveness of P2Y12 Inhibitor Selection Based on the CYP2C19 Loss-of-Function Allele: A Semi-Systematic Review.
- Published in:
- Cardiogenetics, 2024, v. 14, n. 2, p. 59, doi. 10.3390/cardiogenetics14020005
- By:
- Publication type:
- Article